Daisy Alapat Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Researcher

University of Arkansas for Medical Sciences

unknown

3 h-index 8 pubs 48 cited

Research Areas

Health Sciences Research and Education Immune Response and Inflammation Child and Adolescent Health Health disparities and outcomes Cancer Treatment and Pharmacology Lymphoma Diagnosis and Treatment Meta-analysis and systematic reviews

Links

ORCID Lab Website Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Daisy Alapat's research focuses on idiopathic multicentric Castleman disease (MCD), investigating treatment strategies and disease burden. Her work has examined the effectiveness of treatments consistent with established guidelines, noting associations with improved patient outcomes. Alapat has also contributed to understanding the longitudinal natural history of MCD, characterizing its disease burden and the heterogeneity within the disease, including the oligocentric subtype, through registry data. Her publications explore the increased comorbidities and hospitalizations linked to idiopathic MCD and evaluate the variable response rates across different chemotherapy regimens for severe forms of the disease. Additionally, her research has addressed pediatric idiopathic MCD, highlighting its severity and response to specific treatments like siltuximab. Alapat is certified in Anatomic Pathology/Clinical Pathology and Hematopathology.

Metrics

  • h-index: 3
  • Publications: 8
  • Citations: 48

Selected Publications

  • Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab (2025) DOI
  • Variable response rates across chemotherapy regimens for severe idiopathic multicentric Castleman disease. (2025) DOI
  • Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry (2025) DOI
  • Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease (2024) DOI
  • Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes (2023) DOI

Collaborators

Researchers in the database who share publications

Frits van Rhee University of Arkansas for Medical Sciences 3 shared publications

Similar Researchers

Based on overlapping research topics

Tripti Shukla University of Arkansas for Medical Sciences
Health Sciences Research and Education Child and Adolescent Health Health disparities and outcomes
Good match 4 shared topics
Matthew Kelly University of Arkansas for Medical Sciences
Health Sciences Research and Education Immune Response and Inflammation Child and Adolescent Health
Good match 4 shared topics
Sri Usha Jeevani Obulareddy University of Arkansas for Medical Sciences
Health Sciences Research and Education Immune Response and Inflammation Health disparities and outcomes
Good match 5 shared topics
Mamatha Gaddam University of Arkansas for Medical Sciences
Immune Response and Inflammation Health disparities and outcomes Cancer Treatment and Pharmacology
Good match 5 shared topics
A. G. P. Brown University of Arkansas for Medical Sciences
Immune Response and Inflammation Child and Adolescent Health Cancer Treatment and Pharmacology
Good match 4 shared topics
Alexandra Theisen University of Arkansas for Medical Sciences
Health Sciences Research and Education Immune Response and Inflammation Child and Adolescent Health
Good match 3 shared topics